POSNER BRIAN M

SEC source: 0001213900-26-104669 · ownership.xml · derivative · entry 1

POSNER BRIAN M · CIK 0001287711 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,962

Underlying: Common Stock · 84,033 shares

Expires not disclosed

F1 · derivative.exercise_price: On September 25, 2026, the Reporting Person was granted 84,033 deferred stock units ("DSUs") under the Issuer's 2024 Long-Term Incentive Plan, which vest quarterly over a twelve (12)-month period. Each DSU represents a contingent right to receive one share of the Issuer's common stock.

F1 · derivative.exercise_date: On September 25, 2026, the Reporting Person was granted 84,033 deferred stock units ("DSUs") under the Issuer's 2024 Long-Term Incentive Plan, which vest quarterly over a twelve (12)-month period. Each DSU represents a contingent right to receive one share of the Issuer's common stock.

F1 · derivative.expiration_date: On September 25, 2026, the Reporting Person was granted 84,033 deferred stock units ("DSUs") under the Issuer's 2024 Long-Term Incentive Plan, which vest quarterly over a twelve (12)-month period. Each DSU represents a contingent right to receive one share of the Issuer's common stock.

SEC source: 0001213900-26-090157 · ownership.xml · nonDerivative · entry 1

POSNER BRIAN M · CIK 0001287711 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,564

F1 · shares: Vests as to 1,415 shares on each of September 30, 2026, December 31, 2026, March 31, 2027, and June 30, 2027.

SEC source: 0001213900-25-104095 · ownership.xml · derivative · entry 1

POSNER BRIAN M · CIK 0001287711 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,929

Underlying: Common Stock · 49,262 shares

Expires not disclosed

F1 · derivative.exercise_price: On October 28, 2025, the Reporting Person was granted 49,262 deferred stock units ("DSUs") under the Issuer's 2024 Long-Term Incentive Plan, which vest quarterly over a twelve (12)-month period. Each DSU represents a contingent right to receive one share of the Issuer's common stock.

F1 · derivative.exercise_date: On October 28, 2025, the Reporting Person was granted 49,262 deferred stock units ("DSUs") under the Issuer's 2024 Long-Term Incentive Plan, which vest quarterly over a twelve (12)-month period. Each DSU represents a contingent right to receive one share of the Issuer's common stock.

F1 · derivative.expiration_date: On October 28, 2025, the Reporting Person was granted 49,262 deferred stock units ("DSUs") under the Issuer's 2024 Long-Term Incentive Plan, which vest quarterly over a twelve (12)-month period. Each DSU represents a contingent right to receive one share of the Issuer's common stock.

SEC source: 0001437749-25-007341 · rdgdoc.xml · derivative · entry 1

POSNER BRIAN M · CIK 0001287711 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 16,667 shares

Expires not disclosed

F1 · derivative.exercise_price: On March 10, 2025, the Reporting Person was granted 16,667 DSUs under the Issuer's 2024 Long-Term Incentive Plan. A total of 8,333 DSUs vested immediately on the date of grant. Another 4,167 DSUs will vest on June 10, 2025, and an additional 4,167 DSUs will vest on September 10, 2025. Each DSU represents a contingent right to receive one share of common stock of the Issuer.

F1 · derivative.exercise_date: On March 10, 2025, the Reporting Person was granted 16,667 DSUs under the Issuer's 2024 Long-Term Incentive Plan. A total of 8,333 DSUs vested immediately on the date of grant. Another 4,167 DSUs will vest on June 10, 2025, and an additional 4,167 DSUs will vest on September 10, 2025. Each DSU represents a contingent right to receive one share of common stock of the Issuer.

F1 · derivative.expiration_date: On March 10, 2025, the Reporting Person was granted 16,667 DSUs under the Issuer's 2024 Long-Term Incentive Plan. A total of 8,333 DSUs vested immediately on the date of grant. Another 4,167 DSUs will vest on June 10, 2025, and an additional 4,167 DSUs will vest on September 10, 2025. Each DSU represents a contingent right to receive one share of common stock of the Issuer.

SEC source: 0001193805-24-000050 · e619191_4-posner.xml · nonDerivative · entry 1

POSNER BRIAN M · CIK 0001287711 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,437

F1 · shares: Represents a grant of Restricted Stock Units of the Issuer. The grant vests (i) with respect to 33% of the underlying shares of Common Stock on each of the first, second, and third anniversaries of the date of grant, in each case provided that the Reporting Person remains in continuous service with the Issuer or an affiliate through the applicable vesting date, and (ii) if and to the extent not already vested, in the case of termination of the Reporting Person without "cause" or resignation for "good reason" within two years after a "change in control" as such terms are defined in the Issuer's Executive Severance Policy.

SEC source: 0001193805-23-001052 · e618823_4-posner.xml · derivative · entry 1

POSNER BRIAN M · CIK 0001287711 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2033-07-31

F1 · derivative.exercise_date: The option vests (i) with respect to 33% of the underlying shares of Common Stock on each of the first, second, and third anniversaries of the date of grant, in each case provided that the Reporting Person remains in continuous service with the Issuer or an affiliate through the applicable vesting date, and (ii) if and to the extent not already vested, in the case of termination of the Reporting Person without "cause" or resignation for "good reason" within two years after a "change in control" as such terms are defined in the Issuer's Executive Severance Policy.

SEC source: 0001193805-22-000080 · ownership.xml · derivative · entry 1

POSNER BRIAN M · CIK 0001287711 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2032-01-14

F1 · derivative.exercise_date: The option vests (i) with respect to 33% of the underlying shares of Common Stock on each of the first, second, and third anniversaries of the date of grant, in each case provided that the Reporting Person remains in continuous service with the Issuer or an affiliate through the applicable vesting date, and (ii) if and to the extent not already vested, in the case of termination of the Reporting Person without "cause" or resignation for "good reason" within two years after a "change in control" as such terms are defined in the Issuer's Executive Severance Policy.

SEC source: 0001193805-21-001730 · e621150_4-posner.xml · nonDerivative · entry 1

POSNER BRIAN M · CIK 0001287711 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,555

SEC source: 0001193805-21-001547 · e621067_4-posner.xml · nonDerivative · entry 1

POSNER BRIAN M · CIK 0001287711 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,555

SEC source: 0001193805-21-001202 · e620887_4-posner.xml · nonDerivative · entry 1

POSNER BRIAN M · CIK 0001287711 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,555

F1 · kind: Reflects the sale of 6,478 shares to pay withholding taxes due to vesting and delivery to the reporting person of the final tranche of 73,033 restricted stock units awarded in June 2019.

F1 · shares: Reflects the sale of 6,478 shares to pay withholding taxes due to vesting and delivery to the reporting person of the final tranche of 73,033 restricted stock units awarded in June 2019.

SEC source: 0001193805-21-000049 · e620213_4-posner.xml · derivative · entry 1

POSNER BRIAN M · CIK 0001287711 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2031-01-18

F1 · derivative.exercise_date: The option vests (i) with respect to 25% of the underlying shares of Common Stock on each of the first, second, third, and fourth anniversaries of the date of grant, in each case provided that the Reporting Person remains in continuous service with the Issuer or an affiliate through the applicable vesting date, and (ii) if and to the extent not already vested, in the case of termination of the Reporting Person without "cause" or resignation for "good reason" within two years after a "change in control" as such terms are defined in the Issuer's Executive Severance Policy.

SEC source: 0001493152-20-011297 · ownership.xml · derivative · entry 1

POSNER BRIAN M · CIK 0001287711 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,000

Underlying: Common Stock · 105,000 shares

Expires 2030-06-12

F1 · derivative.exercise_date: The option vests (i) with respect to 25% of the underlying shares of Common Stock on each of the first, second, third, and fourth anniversaries of the date of grant, and (ii) if and to the extent not already vested, on the date immediately prior to a change of control, in each case provided that the Reporting Person remains in continuous service with the Issuer or an affiliate through the applicable vesting date.

SEC source: 0000899243-19-018613 · doc4.xml · derivative · entry 1

POSNER BRIAN M · CIK 0001287711 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,033

Underlying: Common Stock · 73,033 shares

Expires 2029-06-27

F1 · derivative.exercise_date: 50% of the Restricted Stock Units vest 12 months from the grant date, 25% vest 18 months from the grant date, and the remainder vests 24 months from the grant date.

SEC source: 0000899243-19-015902 · doc4.xml · nonDerivative · entry 1

POSNER BRIAN M · CIK 0001287711 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

SEC source: 0001144204-19-002088 · tv511257_4.xml · derivative · entry 1

POSNER BRIAN M · CIK 0001287711 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2029-01-17

F1 · derivative.exercise_date: This option grant is a contingent grant subject to the following conditions: (i) approval by Cellectar's stockholders of an increase in shares available under the Amended and Restated 2015 Stock Incentive Plan at the Corporation's 2019 annual meeting of stockholders or other special meeting of stockholders called for such purpose; and (ii) to the extent stockholder approval is received, the grant shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date.

SEC source: 0001144204-18-053877 · tv504842_form4.xml · derivative · entry 1

POSNER BRIAN M · CIK 0001287711 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,000

Underlying: Common Stock · 54,000 shares

Expires 2028-10-12

F1 · derivative.exercise_date: This option grant was divided into a definitive grant of 25,559 shares, which vest as to all shares on the first anniversary of the grant date, and a contingent grant of 28,441 shares, which are subject to the following conditions: (i) approval by Cellectar's stockholders of an increase in shares available under the Amended and Restated 2015 Stock Incentive Plan at the Corporation's 2019 annual meeting of stockholders or other special meeting of stockholders called for such purpose; and (ii) to the extent stockholder approval is received, the contingent grant shall vest over a period of three years from the grant date, vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date.

SEC source: 0001144204-18-019628 · v490606_4.xml · derivative · entry 1

POSNER BRIAN M · CIK 0001287711 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2028-04-06

F1 · derivative.exercise_date: Options vest in equal annual increments over a period of three years from the date of grant.

SEC source: 0001144204-17-049476 · v475769_4.xml · nonDerivative · entry 1

POSNER BRIAN M · CIK 0001287711 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 476,421

F1 · shares: Represents shares of restricted stock withheld to pay Mr. Posner's tax withholding obligations incurred in connection with the vesting of 205,715 shares of restricted stock on September 21, 2017.

SEC source: 0001144204-17-034639 · v469949_4.xml · nonDerivative · entry 1

POSNER BRIAN M · CIK 0001287711 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 547,254

F1 · shares: Represents a restricted stock award that is subject to forfeiture until vested. The award vests fully on the date, if any, the Issuer files financial statements with the SEC on Form 10-K or Form 10-Q that report a positive adjusted EBITDA for the Company for two consecutive fiscal quarters, subject to the Reporting Person's continued service through the applicable vesting date and the terms and conditions of the Alliqua BioMedical, Inc. 2014 Long-Term Incentive Plan and that certain restricted stock award agreement by and between the Issuer and the Reporting Person, effective as of June 28, 2017.

SEC source: 0001144204-17-033938 · v469569_4.xml · nonDerivative · entry 1

POSNER BRIAN M · CIK 0001287711 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 447,254

F1 · shares: Represents the Reporting Person's 2016 year-end bonus paid in shares of restricted stock in lieu of cash based on the value of the Issuer's common stock on February 27, 2017. This award is subject to forfeiture until vested, with 100% vesting on September 21, 2017, subject to the Reporting Person's continued service through the applicable vesting date and the terms and conditions of the Alliqua BioMedical, Inc. 2014 Long-Term Incentive Plan and that certain restricted stock award agreement by and between the Issuer and the Reporting Person, effective as of June 23, 2017.